Dabur

On August 22, 2024, Dabur India Limited, a leading Ayurvedic and natural FMCG company, signed a Memorandum of Understanding (MoU) with the Government of Tamil Nadu to establish a new consumer goods manufacturing facility in the state. This will mark Dabur's first manufacturing unit in South India.

In May 2024, Dabur GlucoPlus-C, a dominant player in glucose category, has expanded its portfolio and entered the ready-to-drink glucose category with the launch of 'Dabur GlucoPlus-C Instant Energy Drink' in a PET bottle, in a tasty tangy orange variant.

In March 2024, in a move that's testament to gender parity across workplaces, Dabur India Limited has set up an all-women production line with 100% women employees at its largest-ever greenfield plant near Indore.

In January 2024, the Board of Directors of Dabur India Limited today approved an investment of Rs. 135 crore (US$ 16.19 million) for setting up a new manufacturing facility in South India.

India’s largest Science-based Ayurveda major Dabur India Ltd has now become a ‘Plastic Waste Positive company’ in India, having collected, processed and recycled 35,000 MT of post-consumer plastic waste from all over India in the 2022-23 financial year.

Dabur, in partnership with Ennoble, revamps government middle school at Bari Shah da Talab, Jammu.

In December 2022, Dabur India announced its entry into the women’s personal hygiene space with the launch of Fem Ultra Care Sanitary Napkins.

In October 2022, Dabur India Limited acquired 51% stake in Badshah Masala Private Limited to expand its foods business to Rs. 500 Crore (US$ 60.3 million) in 3 years and expand into new adjacent categories.

In 2022, Dabur India has become a complete plastic waste neutral firm in the country after collecting, processing, and recycling around 27,000 metric tonnes of post-consumer plastic waste.

In April 2022, Dabur India announced plans to induct a fleet of 100 Electric Vehicles in its supply chain for last-mile product distribution.

Dabur India, formed an exclusive partnership with energy provider Indian Oil, which will give Dabur's products direct access to around 140 million Indane LPG consumer households across India.

In September 2021, Dabur entered the face wash category with the launch of Vatika face wash.

Dabur set up a new plant in Madhya Pradesh for the manufacturing of food products, ayurvedic medicines and health supplements with an investment of Rs. 550 crore (US$ 75.6 million).

Dabur expanded the Vatika portfolio with the launch of ‘Vatika Germ Protection Shampoo.

Dabur launched ‘Vatika Select’, a premium range of shampoos, expanding its product portfolio.

Dabur incorporated Herbo dynamic India, a consumer care manufacturer as a wholly-owned subsidiary of the company.

Dabur entered the edible oil segment with the launch of ‘Dabur Cold Pressed Mustard Oil’.

Dabur announced the expansion of its Healthcare OTC portfolio with the launch of ‘Dabur Tulsi Drops’, an ayurvedic remedy to help build respiratory health and provide protection from cough and cold.

Dabur announced the expansion of its Baby Care portfolio with the launch of eight new products for ‘Dabur Baby Range’.

Dabur launched an entire range of ayurvedic baby products only on the e-commerce sales platform.

For excellence in Corporate Governance, Dabur won the ICSI National Award.

Dabur acquired D&A Cosmetics Proprietary Ltd and Atlanta Body & Health Products Proprietary Ltd through its subsidiary.

Dabur Gulabari and Dabur Lal Dant Manjan clock a turnover of Rs. 1.00 billion (US$ 14.88 million) each.

Dabur enters professional skin care market and acquires Ajanta Pharma's over-the-counter brand '30-Plus'.

Foray into organized retail, celebrated 10 years of Real and Dabur Foods merged with Dabur India.

Dabur India Ltd.’s turnover crosses the Rs. 10.00 billion (US$ 222.47 million) mark.

Dabur's operations shift to Delhi and a new manufacturing plant is set up in temporary premises in Faridabad on the outskirts of Delhi.

Dabur enters the specialized area of nature-based ayurvedic medicines, for which standardized drugs are not available in the market.

Setting up a manufacturing plant.

Birth of Dabur.